UKBizDB.co.uk

AYRSHIRE COMPLEMENTARY THERAPY

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Ayrshire Complementary Therapy. The company was founded 4 years ago and was given the registration number SC655986. The firm's registered office is in ARDROSSAN. You can find them at 15 Kilmeny Court, Ayrshire, Ardrossan, . This company's SIC code is 86210 - General medical practice activities.

Company Information

Name:AYRSHIRE COMPLEMENTARY THERAPY
Company Number:SC655986
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:28 February 2020
Jurisdiction:Scotland
Industry Codes:
  • 86210 - General medical practice activities
  • 86220 - Specialists medical practice activities
  • 86900 - Other human health activities

Office Address & Contact

Registered Address:15 Kilmeny Court, Ayrshire, Ardrossan, Scotland, KA22 8DJ
Country Origin:SCOTLAND
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
15, Kilmeny Court, Ayrshire, Ardrossan, Scotland, KA22 8DJ

Secretary08 May 2020Active
15, Kilmeny Court, Ayrshire, Ardrossan, Scotland, KA22 8DJ

Director28 February 2020Active
15, Kilmeny Court, Ayrshire, Ardrossan, Scotland, KA22 8DJ

Secretary28 February 2020Active

People with Significant Control

Dr Anthony Brennan
Notified on:28 February 2020
Status:Active
Date of birth:October 1994
Nationality:British
Country of residence:Scotland
Address:15, Kilmeny Court, Ardrossan, Scotland, KA22 8DJ
Nature of control:
  • Voting rights 75 to 100 percent
  • Right to appoint and remove directors

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (3 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (11 months ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (1 months remaining)

Copyright © 2024. All rights reserved.